These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28067349)

  • 1. The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity.
    Qu A; Huang F; Li A; Yang H; Zhou H; Long J; Shi L
    Chem Commun (Camb); 2017 Jan; 53(7):1289-1292. PubMed ID: 28067349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
    Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
    Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical assay and molecular mechanism of aggregation inhibitors of beta-amyloid.
    Akikusa S; Watanabe KI; Horikawa E; Nakamura K; Kodaka M; Okuno H; Konakahara T
    J Pept Res; 2003 Jan; 61(1):1-6. PubMed ID: 12472843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ac-LVFFARK-NH
    Zhang H; Dong X; Liu F; Zheng J; Sun Y
    Biophys Chem; 2018 Apr; 235():40-47. PubMed ID: 29453052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro.
    Chen G; Andrade-Talavera Y; Tambaro S; Leppert A; Nilsson HE; Zhong X; Landreh M; Nilsson P; Hebert H; Biverstål H; Fisahn A; Abelein A; Johansson J
    Commun Biol; 2020 Jan; 3(1):32. PubMed ID: 31959875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly and Anti-Amyloid Cytotoxicity Activity of Amyloid beta Peptide Derivatives.
    Castelletto V; Ryumin P; Cramer R; Hamley IW; Taylor M; Allsop D; Reza M; Ruokolainen J; Arnold T; Hermida-Merino D; Garcia CI; Leal MC; Castaño E
    Sci Rep; 2017 Mar; 7():43637. PubMed ID: 28272542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and Degradation of Amyloid Beta (Aβ40) Fibrillation by Designed Small Peptide: A Combined Spectroscopy, Microscopy, and Cell Toxicity Study.
    Ghosh A; Pradhan N; Bera S; Datta A; Krishnamoorthy J; Jana NR; Bhunia A
    ACS Chem Neurosci; 2017 Apr; 8(4):718-722. PubMed ID: 28061031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.
    De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D
    FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the aggregation mechanism of Aβ(25-40).
    Xiong J; JiJi RD
    Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity.
    Kumar J; Namsechi R; Sim VL
    PLoS One; 2015; 10(6):e0129087. PubMed ID: 26070139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Derived Hexapeptide AcPHF6 Promotes Beta-Amyloid (Aβ) Fibrillogenesis.
    Mohamed T; Gujral SS; Rao PPN
    ACS Chem Neurosci; 2018 Apr; 9(4):773-782. PubMed ID: 29239599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
    Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.